The EACH/PIC Coalition submitted a group letter signed by 22 organizations to the Maryland PDAD in response to proposed regulations defining the circumstances under which use of a drug may […]
The EACH/PIC Coalition submitted a group letter signed by 25 organizations opposing the creation of an upper payment limit for Cosentyx. The letter stated: “We support efforts to improve affordability
The EACH/PIC Coalition submitted comments to the Oregon PDAB, providing input into policy recommendations to consider for inclusion in the 2026 annual report to the legislature. The letter stated: “Throughout
The EACH/PIC Coalition submitted a letter to the Louisiana Governor Jeff Landry opposing the creation of a PDAB in the state and urging for the bill to be vetoed. The
The EACH/PIC Coalition submitted a letter to the Maryland PDAB in response to proposed changes to the Cost Review Study Process. The letter stated: “Ultimately, the board’s cost review is
May 21, 2026 The EACH/PIC Coalition issued the following statement on Most-Favored-Nation-style price-setting policies: “The EACH/PIC Coalition remains concerned that most favored nation proposals are unlikely to deliver meaningful savings
May 19, 2026 Mark Hobraczk, legislative lead for the EACH/PIC Coalition, issued the following statement in response to Governor Abigail Spanberger’s veto of H.B. 483 / S.B. 271: “Governor Spanberger
By Scott Maucione “The Maryland Prescription Drug Affordability Board (PDAB) voted Monday to put payment caps on Ozempic for state and local governments, which will save those entities about $5.8
By Danielle Brown “State officials determined that Ozempic, a popular diabetes treatment and weight-loss drug, is unaffordable for Marylanders and voted Monday to limit how much state and local governments
May 18, 2026 Tiffany Westrich-Robertson, EACH/PIC Coalition founder and person living with an autoimmune condition, issued the following statement on the Maryland Prescription Drug Affordability Board vote on implementing an
